Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! We’re joined by Karla Lester, a pediatrician and certified life and weight coach. Together, we explore the journey of Lizzie and her mother, Jackie, as they navigate…
Category: Diabetes
A lesson in generosity: How one woman helped a stranger afford insulin
I waited in line at the pharmacy, a familiar chain store. The man in front of me waited patiently for the technician to ring up his meds. I overheard her say to him, “$125.00. That includes your insulin.” The man bowed his head and smiled p…
A story of liver cancer and diabetes [PODCAST]
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! Join us for a discussion on the critical intersection of diabetes and liver disease. Our guest, Sarah Bauer, a pediatrician, shares her personal journey and insights into …
Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans
Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data. Wegovy, a drug that is approved for weight loss, is covered by just 1% of Marketplace…
Applying the 2024 ADA standards of care into practice: a practical approach to basal insulin in Type 2 diabetes
In this special sponsored episode from Sanofi, we welcome Jennifer Goldman. She is a professor of pharmacy at the Massachusetts College of Pharmacy and Health Sciences, board-certified in advanced diabetes management, and a certified diabetes care and …
It is time to change the conversation and eliminate the stigma attached to diabetes
The Canadian federal government’s decision to cover diabetes medication and devices under its new pharmacare plan is a significant step forward in improving the quality of life for the millions of Canadians with diabetes, especially those who str…
High Price of Popular Diabetes Drugs Deprives Low-Income People of Effective Treatment
The makers of Ozempic and Mounjaro charge list prices of around $1,000 a month for the diabetes and obesity drugs, and insurers are reluctant to pick up the tab. Often, low-income patients have to resort to less effective treatments.
Can weight loss medication interfere with ADHD meds?
Why bother going to work? If I didn’t work, I wouldn’t get paid, so there was that. But it seemed like a pointless exercise. I would stare at my monitor until it was time to go home. On some level I knew I should be, well, working, but I co…
Health care disparities: Navigating complex care [PODCAST]
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! We delve into the challenges faced by individuals who navigate complex health care systems with multiple chronic conditions. Our guest, Gary Marc Rothenberg, a podiatrist,…
KFF Health Tracking Poll May 2024: The Public’s Use and Views of GLP-1 Drugs
KFF’s latest Health Tracking Poll examines the public’s views and use of an an increasingly popular class of prescription drugs used for weight loss and to treat diabetes or prevent heart attacks or strokes. The poll finds 12% of adults report having t…
